48,874
edits
(→Basal cell carcinoma: more, refs) |
m (→IHC: fix refs) |
||
Line 112: | Line 112: | ||
Panel:<ref>AP. May 2009.</ref> | Panel:<ref>AP. May 2009.</ref> | ||
*CD34 +ve. | *CD34 +ve. | ||
**Usually negative in dermatofibroma.<ref name=pmid7694515> | **Usually negative in dermatofibroma.<ref name=pmid7694515>{{cite journal |author=Abenoza P, Lillemoe T |title=CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans |journal=Am J Dermatopathol |volume=15 |issue=5 |pages=429–34 |year=1993 |month=October |pmid=7694515 |doi= |url=}}</ref><ref name=pmid9129699>{{cite journal |author=Goldblum JR, Tuthill RJ |title=CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma |journal=Am J Dermatopathol |volume=19 |issue=2 |pages=147–53 |year=1997 |month=April |pmid=9129699 |doi= |url=}}</ref> | ||
*Factor XIIIa -ve. | *Factor XIIIa -ve. | ||
**Usually positive in dermatofibroma.<ref name=pmid7694515> | **Usually positive in dermatofibroma.<ref name=pmid7694515>{{cite journal |author=Abenoza P, Lillemoe T |title=CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans |journal=Am J Dermatopathol |volume=15 |issue=5 |pages=429–34 |year=1993 |month=October |pmid=7694515 |doi= |url=}}</ref><ref name=pmid9129699>{{cite journal |author=Goldblum JR, Tuthill RJ |title=CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma |journal=Am J Dermatopathol |volume=19 |issue=2 |pages=147–53 |year=1997 |month=April |pmid=9129699 |doi= |url=}}</ref> | ||
*S100 -ve (screen for melanoma). | *S100 -ve (screen for melanoma). | ||
*caldesmin -ve (screen for muscle differentiation). | *caldesmin -ve (screen for muscle differentiation). |
edits